Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Dow
Johnson and Johnson
UBS
Fuji
Fish and Richardson
Cantor Fitzgerald
Covington

Generated: April 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: bivalirudin

« Back to Dashboard

bivalirudin

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
The Medicines Co ANGIOMAX bivalirudin INJECTABLE;INTRAVENOUS 020873 NDA AUTHORIZED GENERIC Sandoz N 0781-3158-95
The Medicines Co ANGIOMAX bivalirudin INJECTABLE;INTRAVENOUS 020873 NDA AUTHORIZED GENERIC Sandoz N 0781-9158-95
The Medicines Co ANGIOMAX bivalirudin INJECTABLE;INTRAVENOUS 020873 NDA The Medicines Company N 65293-001-01
Apotex Inc BIVALIRUDIN bivalirudin INJECTABLE;INTRAVENOUS 204876 ANDA Apotex corp N 60505-6101-4
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cerilliant
Teva
Chinese Patent Office
Medtronic
AstraZeneca
McKesson
McKinsey
Citi